Prenetics
Hong Kong · Founded 2014
About Prenetics
Prenetics is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the top sports distribution companies in the USA. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by ‘enhancing life through science’.
Company Facts
- Founded: 2014
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $235.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:PRE
- Website: prenetics.com
- Phone: +852 2210 9588
Industries & Categories
Biotechnology, Genetics, Health Care, Health Diagnostics, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/prenetics-71510 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.